Catalog Products
- News Center:
- Home>
- News Center>
- Company News>
- News Details
Product Recommendation | S-2772: A Chromogenic Substrate for Factor Xa Activity Assay and Anti-Xa Testing
2026/11/19 15:14:48 Browse volume(20)S-2772
During coagulation, Factor Xa (FXa) is a key node connecting the coagulation cascade with anticoagulant regulation. It not only participates in thrombin generation but also serves as a key target for various anticoagulants and anticoagulant drugs.
For example, antithrombin III (ATIII) inhibits FXa activity, while heparin and low-molecular-weight heparin enhance this inhibitory effect. Direct oral anticoagulants (DOACs), such as rivaroxaban, directly inhibit FXa.
Although their mechanisms of action differ, these detection systems can all be analyzed based on changes in FXa activity.
How, then, can the enzymatic reaction of FXa be converted into a measurable detection signal? What application support can an FXa chromogenic substrate provide for different coagulation assays?
Based on this detection approach, FXa chromogenic substrates serve as important raw materials connecting enzymatic reactions with detectable signals.
The product featured in this issue, S-2772, is a tripeptide chromogenic substrate designed for FXa-mediated enzymatic reactions.
I. Featured Product: S-2772
Chinese Name: Chromogenic Substrate S-2772
English Name: Ac-D-Arg-Gly-Arg-pNA · 2HCl
Abbreviation: S-2772
CAS No.: 113711-88-9
Molecular Formula: C22H37Cl2N11O6
Molecular Weight: 622.51
Specifications: 1 g/5 g/25 g (Custom packaging available)
Appearance: Off-white crystalline powder
Product Code: G04010005
Color Development: Yellow
S-2772 is a tripeptide chromogenic substrate that primarily acts on coagulation Factor Xa. Through enzymatic hydrolysis, it releases p-nitroaniline (pNA), enabling the absorbance-based detection of FXa catalytic activity.
II. How Does S-2772 Convert FXa Activity into a Chromogenic Signal?
To understand the applications of S-2772, it is first necessary to understand how it participates in the enzymatic reaction of FXa.
S-2772 consists of an Ac-D-Arg-Gly-Arg peptide chain and a terminal pNA chromogenic group. The peptide chain is involved in substrate recognition by FXa, while pNA serves as the chromogenic reporter group.
When FXa acts on S-2772, it hydrolyzes the amide bond between the terminal Arg residue and pNA, releasing yellow p-nitroaniline.
This process can be summarized as follows:
S-2772 → FXa-mediated enzymatic hydrolysis → pNA release → Yellow chromogenic signal
By monitoring changes in absorbance around 405 nm, pNA release can be measured, thereby evaluating the catalytic activity of FXa.
In this reaction, higher FXa activity generally results in a faster rate of pNA release and more pronounced changes in absorbance. When FXa is inhibited, substrate hydrolysis slows down accordingly, resulting in a weaker chromogenic signal.
This characteristic enables S-2772 to be used not only for measuring FXa activity itself but also for extending its applications to other coagulation assay systems by detecting residual FXa activity under different inhibitory mechanisms.
III. From Enzyme Activity Measurement to Anticoagulant Evaluation: Applications of S-2772
The same chromogenic reaction can serve different detection purposes in different assay systems. Based on changes in FXa activity, S-2772 has three main application directions.
1. Direct FXa Activity Measurement: Evaluating the Catalytic Activity of Factor Xa
As an important serine protease in the coagulation cascade, Factor Xa is an important indicator in coagulation-related enzymatic studies.
S-2772 can serve as a chromogenic substrate for FXa. By measuring the amount or rate of p-nitroaniline released during the enzymatic reaction, the catalytic activity of FXa can be determined.
In this assay system, FXa acts directly on S-2772, and the chromogenic signal generated by substrate hydrolysis correlates with enzyme activity, providing a basis for FXa activity evaluation and reaction kinetics analysis.
Main Applications:
• Factor Xa activity measurement
• FXa enzymatic reaction kinetics studies
• Development of FXa chromogenic assays
2. Antithrombin III Activity Assay: Evaluating Anticoagulant Activity Through Residual FXa Activity
Antithrombin III is an important natural anticoagulant in the human body. It inhibits the activity of coagulation factors such as FXa and plays an important role in maintaining the balance between coagulation and anticoagulation.
In ATIII activity assays, the ATIII in a sample is generally first allowed to react with a defined amount of FXa, after which a chromogenic substrate is added to measure the remaining FXa activity.
In this process, S-2772 is used to detect residual enzyme activity.
When ATIII activity in the sample is higher, its inhibitory effect on FXa is generally stronger. The amount of residual FXa in the reaction system decreases, reducing the hydrolysis rate of S-2772 and ultimately producing a weaker chromogenic response.
Therefore, ATIII activity can be indirectly evaluated by measuring residual FXa activity in combination with an appropriate calibration system.
Main Applications:
• Antithrombin III activity measurement
• Development of antithrombin III activity assays
• R&D of antithrombin III activity assay kits
3. Rivaroxaban Detection: Analyzing Drug Concentration Through FXa Inhibition
In addition to natural anticoagulants, some anticoagulant drugs also target FXa directly. One example is rivaroxaban, an oral anticoagulant that directly inhibits FXa activity, reduces thrombin generation, and thereby produces an anticoagulant effect.
This mechanism of action also provides an approach for drug concentration measurement.
In rivaroxaban assays, a defined amount of FXa is first allowed to undergo an inhibition reaction with rivaroxaban in the sample. S-2772 is then added to measure the residual FXa activity.
As the rivaroxaban concentration increases, its inhibitory effect on FXa generally becomes stronger. The amount of residual FXa capable of hydrolyzing S-2772 decreases, resulting in reduced pNA release and a weaker chromogenic response.
By establishing a calibration curve using rivaroxaban standards at different concentrations, residual FXa activity can be converted into the corresponding drug concentration.
Main Applications:
• Rivaroxaban concentration measurement
• Development of rivaroxaban anti-Xa assays
• R&D of rivaroxaban assay kits
It should be noted that although both rivaroxaban assays and conventional heparin anti-Xa assays can use FXa chromogenic substrates, their mechanisms of action, calibrators, and result reporting methods differ. Their assay systems and calibration curves cannot be used interchangeably.
IV. From Molecular Structure to Assay Systems: Key Advantages of S-2772
✅ Clear Application Pathways, Supported by Established Development References
From FXa activity measurement to ATIII assays and anti-Xa assay development, the applications of S-2772 are supported by patent examples and enzymatic principles, helping customers quickly identify suitable application directions.
✅ Compatibility with Aqueous Systems for Greater Flexibility in Reagent Development
Its dihydrochloride salt form provides a structural basis for developing aqueous chromogenic reagents, facilitating formulation design and condition optimization for aqueous assay systems.
✅ Compatible with Automated Testing and Assay Optimization, Enhancing Method Development Flexibility
The pNA released by S-2772 can be monitored through changes in absorbance, making it suitable for kinetic chromogenic analysis and automated assay development. Meanwhile, substrate concentration, reaction time, and other reaction conditions can be adjusted according to the detection target to explore reaction systems better suited to specific assay requirements.
✅ Short Peptide Design for a More Streamlined Synthesis Process
S-2772 is a tripeptide substrate with an Ac protecting group at the N-terminus. Its synthesis steps and purification procedures are relatively straightforward, making it suitable for reagent development projects with cost optimization requirements.
Extended Services
Using FXa chromogenic detection as a foundation, S-2772 supports ATIII and anti-Xa assay development.
For more coagulation assay chromogenic substrates or custom packaging services, please call +86 13302967066!
Hepattack Bioscience & Technology is committed to providing reliable domestic alternatives for gene sequencing, molecular diagnostics, and microbial testing.
For related products such as blood cell dyes and buffer salts, please visit the [MedSun Biotechnology Website] to explore the complete product range and technical specifications.
Founded in 2015, it is a high-tech enterprise focusing on microbial testing、 gene sequencing and in vitro molecular diagnostics in the R&D, production, and sales of biochemical reagent raw materials. Committed to providing high-quality biochemical reagent raw materials and professional custom synthesis services, the product portfolio covers more than a dozen categories and nearly a thousand innovative products. Upholding the core philosophy of “customer first, integrity and professionalism”, we serve with dedication to meet customers’ diverse needs in research and testing.
Official WeChat account: Shenzhen Hepattack Bioscience & Technology Co. Ltd.
Official Website: http://www.hepattack.com
Hotline: +86 0755-23251735
QQ: 2370561481
Email: sales@hepattack.com
Related Links
- · FAQs about Hepattack BioTech [2025-01-20]
- · Hot Product | H-Ala-AMC ∙ TFA: Application of an Aminopeptidase Fluorogenic Substrate in Microbial Identification [2026-10-19]
- · In Stock | Chromogenesis Is More Than Just Choosing a Dye: Application of Fast Garnet GBC Base in Enzymatic Chromogenic Systems [2026-10-22]
- · In Stock | From Enzymatic Marker to Chromogenic Media: Applications and Selection Strategy for X-Glc [2026-10-23]
- · How to Simplify Chromogenic Detection? Meet the NAGase Chromogenic Substrate CNP-GlcNAc [2026-10-28]
- · In Stock | From Vibrio Differentiation to Combinatorial Chromogenesis: Application Analysis of Magenta-Glc [2026-11-03]
- · S-2403 Chromogenic Substrate: A Substrate Choice for Plasminogen, Plasmin, and Inhibitor Activity Assays [2026-11-11]
- · Product Recommendation | S-2772: A Chromogenic Substrate for Factor Xa Activity Assay and Anti-Xa Testing [2026-11-19]

